 |
 |
Below is pasted an extract from a post from a Health Reform List to which I belong. It describes a situation where a physician who had a financial interest in a "new treatment" (and who also *edited* the medical journal) was promoting the substance for his own financial gain. This is happening more and more as "managed care" encourages doctors and other health professionals to become "businesspeople". I post this here because of the recent discussions about such things as "magnetic therapy" (for the Parkinson's List) and "Antineoplastons" (for the Braintmr List). ------------------------------------------------------------------ Thomas M. Burton, "Urodollars," Wall Street Journal, March 19, 1998, A1 = reports that a University of Mich. professor of urology was found to be = advocating treatments that used products of a company where he held a = position on the board. Further, the Journal of Urology, which he edited = pushed the same treatments without any disclosure of the editors = position. This troubling case highlights the fact that Academia is now = subject to the same kind of lobbying assault as the political process.=20 ------------------------------------------------------------------- Best, Bob *********************************** ROBERT A. FINK, M. D., F.A.C.S. Neurological Surgery 2500 Milvia Street Suite 222 Berkeley, CA 94704-2636 USA Phone: (510) 849-2555 FAX: (510) 849-2557 WWW: <http://www.dovecom.com/rafink/> mailto:[log in to unmask] "Ex Tristitia Virtus" ***********************************